Pierre Charles
Overview
Explore the profile of Pierre Charles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delestre F, Charles P, Karras A, Pagnoux C, Neel A, Cohen P, et al.
Ann Rheum Dis
. 2023 Nov;
83(2):233-241.
PMID: 37918894
Objective: To compare the long-term efficacy and safety of azathioprine (AZA), 18-month fixed-schedule rituximab (RTX), 18-month tailored RTX and 36-month RTX in preventing relapses in patients with antineutrophil cytoplasmic antibody...
2.
Rohmer J, Nguyen Y, Trefond L, Agard C, Allain J, Berezne A, et al.
J Autoimmun
. 2023 Aug;
139:103093.
PMID: 37536165
Background: The landscape of polyarteritis nodosa (PAN) has substantially changed during the last decades. Recent data regarding causes, characteristics, and prognosis of systemic PAN in the modern era are lacking....
3.
Khoudour N, Delestre F, Jabot-Hanin F, Jouinot A, Nectoux J, Letouneur F, et al.
Arthritis Rheumatol
. 2023 May;
75(11):2003-2013.
PMID: 37134130
Objective: Interindividual variability in response to rituximab remains unexplored in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Rituximab pharmacokinetics (PK) and pharmacodynamics (PD) as well as genetic polymorphisms could contribute to variability....
4.
Samson M, Devilliers H, Thietart S, Charles P, Pagnoux C, Cohen P, et al.
RMD Open
. 2023 Mar;
9(1).
PMID: 36972927
Objective: To develop a score assessing the probability of relapse in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Methods: Long-term follow-up data from GPA and MPA patients included in...
5.
Benichou N, Charles P, Terrier B, Jones R, Hiemstra T, Mouthon L, et al.
Kidney Int
. 2023 Mar;
103(6):1144-1155.
PMID: 36940799
In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), hematuria and proteinuria are biomarkers reflecting kidney involvement at diagnosis. Yet, the prognostic value of their persistence after immunosuppressive induction therapy, reflecting kidney...
6.
Sorin B, Iudici M, Guerry M, Samson M, Bielefeld P, Maillet T, et al.
Rheumatology (Oxford)
. 2023 Feb;
62(11):3662-3671.
PMID: 36847447
Objective: To identify characteristics of granulomatosis with polyangiitis (GPA) associated with induction failure, describe salvage therapies and their efficacy. Methods: We conducted a nationwide retrospective case-control study of GPA with...
7.
Demouche S, Juge P, Charles P, Descamps V, Benali K, Brunet-Possenti F
Dermatol Ther
. 2022 Aug;
35(11):e15797.
PMID: 36038806
No abstract available.
8.
Jeantin L, Lenfant T, Bataille P, de Boysson H, Cathebras P, Agard C, et al.
J Rheumatol
. 2022 Jul;
49(12):1349-1355.
PMID: 35840158
Objective: While myocardial impairment is a predictor of poor prognosis in antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), little is known about valvular involvement. This study aims at describing the clinical...
9.
de Ponfilly-Sotier M, Jachiet V, Benhamou Y, Lahuna C, de Renzis B, Kottler D, et al.
Clin Exp Rheumatol
. 2022 May;
40(7):1336-1342.
PMID: 35579092
Objectives: Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) are associated with systemic inflammatory and autoimmune diseases (SIADs) in 10-30% of cases. The aims of this study were (i) to...
10.
Khellaf L, Cosserat J, Calas A, Brasme H, Charles P
Eur J Dermatol
. 2021 Nov;
31(5):652-654.
PMID: 34789449
No abstract available.